Skip to main content
See every side of every news story
Published loading...Updated

University of Michigan medical center halts gender-affirming care for patients under 19

The suspension follows a federal subpoena amid an investigation into possible abuse of authority by doctors prescribing gender-affirming treatments to minors, according to sources.

  • The University of Michigan announced on August 25 it will no longer provide gender-affirming hormonal therapies and puberty blockers for patients under 19 following a federal subpoena.
  • The decision was made in response to increasing external pressures and risks linked to an ongoing federal inquiry into the provision of gender-affirming treatments for individuals under 19.
  • University of Michigan Health and other institutions received administrative subpoenas similar to those filed earlier this month against the Children’s Hospital of Philadelphia, demanding broad transgender care documents.
  • Advocates like Equality Michigan expressed deep concern, stating this move sends a chilling message to vulnerable youth and leaves a significant gap in transgender health services in Michigan, one of two providers in the state.
  • This suspension reflects increased federal pressure on transgender healthcare, likely worsening access for minors and prompting legal challenges and advocacy efforts to preserve care.
Insights by Ground AI
Does this summary seem wrong?

15 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left
50% Left

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Michigan Advance broke the news in on Monday, August 25, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal